Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population-Reference-Cited by-同舟云学术

Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population

Published:2021-04-10 Issue:6 Volume:37 Page:881-890
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Berger Jeffrey S.¹,Laliberté François²^ORCID,Kharat Akshay³,Lejeune Dominique²^ORCID,Moore Kenneth Todd⁴^ORCID,Jung Young²,Lefebvre Patrick²,Ashton Veronica³^ORCID

Affiliation:

1. New York University School of Medicine, New York, NY, USA

2. Groupe d’analyse, Ltée, Québec, Canada

3. Janssen Scientific Affairs, LLC, Titusville, NJ, USA

4. Janssen Pharmaceuticals, Inc, Titusville, NJ, USA

Funder

Janssen Scientific Affairs, LLC

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1901223

Reference44 articles.

1. Atrial fibrillation

2. Center for Disease Control and Prevention. Atrial fibrillation. [cited 2020 Sep 11]. Available from: https://www.cdc.gov/heartdisease/atrial_fibrillation.htm.

3. Assessing the Risk of Bleeding in Patients With Atrial Fibrillation

4. Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities

5. Obesity and the Risk of New-Onset Atrial Fibrillation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-27

2. Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: A systematic review and meta‐analysis;Health Science Reports;2024-04

3. Factor Xa inhibitors versus warfarin in severely obese patients with venous thromboembolism or atrial fibrillation;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2024-02-29

4. Characterizing the Clinical Adoption of Medical AI Devices through U.S. Insurance Claims;NEJM AI;2023-12-11

5. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios;Journal of Clinical Medicine;2023-09-13